A detailed history of Wc Walker & Associates, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Wc Walker & Associates, Inc. holds 976 shares of LLY stock, worth $776,573. This represents 0.2% of its overall portfolio holdings.

Number of Shares
976
Previous 883 10.53%
Holding current value
$776,573
Previous $316,000 12.97%
% of portfolio
0.2%
Previous 0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 23, 2023

BUY
$321.55 - $374.67 $29,904 - $34,844
93 Added 10.53%
976 $357,000
Q2 2021

Jul 06, 2021

BUY
$180.55 - $233.54 $159,425 - $206,215
883 New
883 $207,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wc Walker & Associates, Inc. Portfolio

Follow Wc Walker & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wc Walker & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wc Walker & Associates, Inc. with notifications on news.